BETAWIN TABLET 100MG

Country: Malaysia

Bahasa: Inggeris

Sumber: NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

Beli sekarang

Risalah maklumat Risalah maklumat (PIL)
28-10-2020
Ciri produk Ciri produk (SPC)
11-10-2023

Bahan aktif:

METOPROLOL TARTRATE

Boleh didapati daripada:

DUOPHARMA (M) SDN. BHD.

INN (Nama Antarabangsa):

METOPROLOL TARTRATE

Unit dalam pakej:

100 Tablets; 500 Tablets

Dikeluarkan oleh:

DUOPHARMA (M) SDN. BHD.

Risalah maklumat

                                _CONSUMER MEDICATION INFORMATION LEAFLET (RIMUP)_
1
BETAWIN TABLET
Metoprolol Tartrate
WHAT IS IN THIS LEAFLET
1.
What BETAWIN TABLET
is used for
2.
How BETAWIN TABLET
works
3.
Before you use BETAWIN
TABLET
4.
How to use BETAWIN
TABLET
5.
While
you
are
using
BETAWIN TABLET
6.
Side effects
7.
Storage and disposal of
BETAWIN TABLET
8.
Product description
9.
Manufacturer and
Pr o d u ct
Registration
Holder
10.
Date of revision
WHAT BE T AW I N
T A B L E T IS USED FOR
BETAWIN TABLET is used
in treatment for hypertension,
angina
pectoris,
suspected
or
definite myocardial infarction,
migraine prophylaxis.
HOW BETAWIN TABLET
WORKS
BETAWIN TABLET
belongs
to a group of medicines called
beta-blockers.
It
works
by
affecting the body’s response
to
some
nerve
impulses,
especially in the heart.
As
a
result,
it
decreases
the
heart’s
need
for
blood
and
oxygen and therefore reduces
the amount of work the heart
has to do. It also widens the
blood vessels in the body, as
well
as
helping
the
heart
to
beat more regularly.
BEFORE
YOU
USE
BETAWIN
TABLET
_-_
_ _
_When you must not use it_
_ _
Do
not
use
BETAWIN
TABLET if you are allergic to
Metaprolol tartrate or any of
the other ingredients listed at
the end of the leaflet.
_-_
_ _
_Before you start to use it_
_ _
Before
taking
BETAWIN
TABLET, you must tell your
doctor o r p h a r m a c i s t i f
y o u
have, or have had, any
of the
following conditions:
•
asthma
•
diabetes
•
an overactive thyroid gland
•
liver problems
•
kidney problems
•
certain types of angina
•
any other heart problem
•
pheochromocytoma
(rare
tumor
of
adrenal
gland
tissue)
If you are not sure if you have,
or
have
had,
any
of
these
conditions,
you
should
raise
those
concerns
with
your
doctor or pharmacist.
Pregnancy:
Ask for your doctor’s advice
if
you are pregnant, or likely
to
become pregnant during
your
course of medication.
BETAWIN TABLET may
affect
your baby if
you are
given it early in pregnancy or
in
the last weeks before your
baby
is due.
Breastfeeding:
Ask for your doctor’s advice
if

                                
                                Baca dokumen lengkap
                                
                            

Ciri produk

                                [DUOPHARMA (M) SDN BHD]
Page 1 of 3
[Revision Date: 11.10.2023]
BETAWIN TABLET
DESCRIPTION:
BETAWIN TABLET 50MG: A 9mm, round, white tablet with markings ‘d’
on both sides.
BETAWIN TABLET 100MG: A 11mm round, scored tablet white in colour with
marking ‘DUO 861’ and a ‘flower’.
COMPOSITION:
BETAWIN TABLET 50 MG: Each tablet contains Metoprolol Tartrate 50 mg.
BETAWIN TABLET 100 MG: Each tablet contains Metoprolol Tartrate 100
mg.
PHARMACODYNAMICS:
Pharmacotherapeutic group: Beta-receptor blocker, selective
ATC code: C07A B02
Metoprolol is a beta1-selective receptor blocker, i.e. metoprolol
affects the beta1-receptors of the heart in lower doses than needed to
affect beta2-receptors in peripheral vessels and bronchi. At
increasing
doses the beta1-selectivity may decrease.
Metoprolol has no beta-stimulating effect and has little
membrane-stimulating effect. Beta-receptor blockers have negative
inotropic and chronotropic effect.
Metoprolol therapy reduces the effect of catecholamines in association
with physical and psychic strain and gives lower heart rate, cardiac
output and blood pressure. In stress situations with an increased
release of adrenaline from the adrenal glands, metoprolol does not
prevent the normal physiological vascular dilation. In therapeutic
doses, metoprolol has less contractile effect on the bronchial muscles
than non-selective beta-blockers. This property enables treatment of
patients with bronchial asthma or other pronounced obstructive lung
diseases with metoprolol in combination with beta2-receptor
stimulants. Metoprolol influences insulin release and carbohydrate
metabolism to less extent than non-selective beta-blockers and
therefore it can also be given to patients with diabetes mellitus. The
cardiovascular reaction in hypoglycaemia, e.g. tachycardia, is less
influenced by metoprolol and the return of blood sugar level to normal
is faster than for non-selective beta-receptor blockers.
In hypertension, Betawin lowers the blood pressure significantly for
more than 24 hours both
                                
                                Baca dokumen lengkap
                                
                            

Dokumen dalam bahasa lain

Risalah maklumat Risalah maklumat Bahasa Melayu 28-10-2020

Cari amaran yang berkaitan dengan produk ini